A small number of people benefit significantly from the SNRIs duloxetine and milnacipran and the tricyclic antidepressants (such as amitriptyline) however many people experience more adverse effects than benefits.
A small number of people benefit significantly from the SNRIs duloxetine and milnacipran. A small number of people benefit significantly from the tricyclic antidepressants (such as amitriptyline). Many people experience more adverse effects than benefits.